Clinical Trial Update: Efficacy Of Copper To Reduce Acquisition Of Microbes and Healthcare-acquired Infections [NA]

View source ↗

Summary

Completed clinical trial evaluating copper's effectiveness in reducing microbial acquisition and healthcare-associated infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthcare-associated Infection

Drugs mentioned

• Copper (copper)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Healthcare-acquired Infection | NA | Status: COMPLETED